natgillin/translations-raw huggingface dataset:
Pharmacokinetics of the combination of ombitasvir 25 mg, paritaprevir 200 mg, and ritonavir 100 mg, with dasabuvir 400 mg were evaluated in subjects with mild (Child-Pugh A), moderate (Child-Pugh B) and severe (Child-Pugh C) hepatic impairment.
Farmakokinetiko kombinacije 25 mg ombitasvirja, 200 mg paritaprevirja in 100 mg ritonavirja s 400 mg dasabuvirja so ocenili pri preiskovancih z blago (Child-Pugh A), zmerno (Child-Pugh B) in hudo (Child- Pugh C) okvaro jeter.
Pharmacokinetics of total darunavir (mean ± SD)
Farmakokinetika celokupnega darunavirja (povprečna vrednost ± SD)
Pharmacokinetics of trastuzumab emtansine in patients with mild (creatinine clearance CLcr 60 to 89 mL/min, n = 254) or moderate (CLcr 30 to 59 mL/min, n = 53) renal impairment were similar to those in patients with normal renal function (CLcr  90 mL/min, n = 361).
Farmakokinetika trastuzumaba emtanzina je bila pri bolnikih z blago (očistek kreatinina [CLcr] od 60 do 89 ml/min, n = 254) ali zmerno (CLcr od 30 do 59 ml/min, n = 53) ledvično okvaro podobna kot pri bolnikih z normalnim delovanjem ledvic (CLcr  90 ml/min, n = 361).
Pharmacokinetics were characterised in MabCampath-naive patients with B-cell chronic lymphocytic leukaemia (B-CLL) who had failed previous therapy with purine analogues.
Farmakokinetične lastnosti so preučevali pri bolnikih s kronično limfocitno levkemijo celic B (B-KLL ), ki še niso bili zdravljeni z zdravilom MabCampath in pri katerih predhodno zdravljenje s purinskimi analogi ni bilo uspešno.
Pharmacokinetics were dose proportional and did not change over time.
Farmakokinetika je bila sorazmerna z odmerkom in se ni spreminjala s časom.
Pharmacokinetics were studied in paediatric patients in 4 clinical studies (BREATHE-3, FUTURE 1, FUTURE-3 and FUTURE-4 see section 5.1).
Farmakokinetiko pri pediatričnih bolnikih so preučevali v 4 kliničnih študijah (BREATHE-3, FUTURE 1, FUTURE-3 in FUTURE-4, glejte poglavje 5.1).
Pharmacolo- gically active substance
Farmakološko aktivna snov
PHARMACOLOGIC PROPERTIES
FARMAKOLOŠKE LASTNOSTI
Pharmacological doses of NovoSeven activate factor X directly on the surface of activated platelets, localized to the site of injury, independently of tissue factor.
Farmakološki odmerki zdravila NovoSeven aktivirajo faktor X neposredno na površini aktiviranih trombocitov, ki se nahajajo na mestu poškodbe, neodvisno od tkivnega faktorja.
Pharmacological effects associated with titration and maintenance treatment
Farmakološki učinki, povezani s titriranjem odmerka in vzdrževalnim zdravljenjem
PHARMACOLOGICAL PARTICULARS
FARMAKOLOŠKE LASTNOSTI
PHARMACOLOGICAL PARTICULARS Pharmacodynamic properties
FARMAKOLOŠKE LASTNOSTI Farmakodinamične lastnosti
PHARMACOLOGICAL PROPERTIES
212 (1,27)
PHARMACOLOGICAL PROPERTIES
9,1 (5,9 - 13,2)
PHARMACOLOGICAL PROPERTIES
LYFJAFRÆÐILEGAR UPPLÝSINGAR
PHARMACOLOGICAL PROPERTIES
Način uporabe
Pharmacologically active substance(s)
Farmakološko aktivna(e) učinkovina(e)
Pharmacotherapeutic group (human normal immunoglobulin): immune sera and immunoglobulins: immunoglobulins, normal human, ATC code: J06BA
Farmakoterapevtska skupina (humani polispecifični imunoglobulin): imunski serumi in imunoglobulini: imunoglobulini humanega izvora, oznaka ATC: J06BA
Pharmacotherapeutic group - Antivirals for systemic use, nucleoside and nucleotide reverse transcriptase inhibitors, ATC Code: J05AF05.
Farmakoterapevtska skupina: Zdravila za sistemsko zdravljenje virusnih infekcij, nukleozidni in nukleotidni inhibitorji reverzne transkriptaze, oznaka ATC: J05AF05.
Pharmacotherapeutic group - Antivirals for systemic use, nucleoside and nucleotide reverse transcriptase inhibitors,ATC Code: J05AF05.
Farmakoterapevtska skupina: Zdravila za sistemsko zdravljenje virusnih infekcij, nukleozidni in nukleotidni inhibitorji reverzne transkriptaze; oznaka ATC: J05AF05.
Pharmacotherapeutic group : anti infectious, ATC code : J07CA
Farmakoterapevtska skupina: kombinacije bakterijskih in virusnih cepiv.
Pharmacotherapeutic group : Fast-acting human insulin analogue.
Farmakoterapevtska skupina: Analog humanega insulina s hitrim delovanjem.
Pharmacotherapeutic group : Interferons ATCvet code : QL03 AB
Farmakoterapevtska skupina: Interferoni, Oznaka ATC vet: QL03 AB
Pharmacotherapeutic group :Fast-acting human insulin analogue.
Farmakoterapevtska skupina: Analog humanega insulina s hitrim delovanjem.
Pharmacotherapeutic group: : Drugs for acid related disorders,Proton pump inhibitors, ATC code: A02BC02
Farmakoterapevtska skupina: zdravila za kislinsko pogojene bolezni, zaviralci protonske črpalke, oznaka ATC: A02BC02
Pharmacotherapeutic group: <not yet assigned>, ATC code: <not yet assigned>
Farmakoterapevtska skupina: <še ni bila dodeljena>, oznaka ATC: <še ni bila dodeljena>
Pharmacotherapeutic group: A08AA Centrally acting antiobesity products, ATC code: A08AA62 bupropion and naltrexone.
Farmakoterapevtska skupina: A08AA zdravila proti debelosti s centralnim delovanjem, oznaka ATC: A08AA62 bupropion in naltrekson.
Pharmacotherapeutic group: ACE inhibitors, combinations.
Farmakoterapevtska skupina: zaviralci ACE, kombinacije.
Pharmacotherapeutic group: Agents acting on the renin-angiotensin system, renin inhibitors, ATC code: C09XA53
Farmakoterapevtska skupina: zdravila z delovanjem na renin-angiotenzinski sistem, zaviralci renina, oznaka ATC: C09XA53
Pharmacotherapeutic group: Agents acting on the renin-angiotensin system; renin inhibitor (aliskiren) combinations with diuretics (hydrochlorothiazide), ATC code: C09XA52
Farmakoterapevtska skupina: zdravila z delovanjem na renin-angiotenzinski sistem, kombinacije zaviralca renina (aliskirena) z diuretiki (s hidroklorotiazidom), oznaka ATC: C09XA52
Pharmacotherapeutic group: all other therapeutic products, antidotes, ATC code: V03AB35 Mechanism of action:
Farmakoterapevtska skupina: Druga zdravila, antidoti, oznaka ATC: V03AB35 Mehanizem delovanja:
Pharmacotherapeutic group: all other therapeutic products, antidotes, ATC code: V03AB37 Mechanism of action
Farmakoterapevtska skupina: druga zdravila, antidoti, oznaka ATC: V03AB37 Mehanizem delovanja
Pharmacotherapeutic group: All other therapeutic products, ATC code: V03AX03 Mechanism of action and pharmacodynamic effects
Farmakoterapevtska skupina: druga nerazvrščna zdravila za različne bolezni, oznaka ATC: V03AX03 Mehanizem delovanja in farmakodinamični učinki
Pharmacotherapeutic group: Amino acids and derivatives; ATC code: A16AA05 Mechanism of action
Farmakoterapevtska skupina: aminokisline in njihovi derivati; oznaka ATC: A16AA05 Mehanizem delovanja
Pharmacotherapeutic group: Anaesthetics, amides, ATC code: NO1BB20 Mechanism of action
Farmakoterapevtska skupina: anestetiki, amidi, oznaka ATC: N01BB20 Mehanizem delovanja
Pharmacotherapeutic group: Anaesthetics, other local anaesthetics, ATC code: N01BX04 Mechanism of action
Farmakoterapevtska skupina: anestetiki, drugi lokalni anestetiki, oznaka ATC: N01BX04 Mehanizem delovanja
Pharmacotherapeutic group: Analgesics, opioids, ATC code: N02AB03 Mechanism of action
Farmakoterapevtska skupina: analgetiki, opioidi; oznaka ATC: N02AB03 Mehanizem delovanja
Pharmacotherapeutic group: Analgesics, other analgesics and antipyretics, ATC code: N02BG08 Mechanism of action
Farmakoterapevtska skupina: Analgetiki, drugi analgetiki in antipiretiki, oznaka ATC: N02BG08 Mehanizem delovanja
Pharmacotherapeutic group: analgesics; opioids;; ATC code N02AB03.
Farmakoterapevtska skupina: analgetiki; opioidi; oznaka ATC N02AB03.
Pharmacotherapeutic group: Angiotensin II antagonists and diuretics, ATC code:C09DA07.
Farmakoterapevtska skupina: antagonisti angiotenzina II in diuretiki, oznaka ATC: C09DA07.
Pharmacotherapeutic Group: Angiotensin II Antagonists, plain ATC Code: C09CA07.
Farmakoterapevtska skupina: antagonisti angiotenzina II, enokomponentna zdravila, oznaka ATC: C09CA07
Pharmacotherapeutic group: angiotensin II antagonists, plain, telmisartan ATCvet code: QC09CA07
Farmakoterapevtska skupina: antagonisti angiotenzina II, enokomponentna zdravila, telmisartan Oznaka ATC vet: QC09CA07
Pharmacotherapeutic group: angiotensin-II antagonists, combinations ATC code: C09D A04
Farmakoterapevtska skupina: antagonisti angiotenzina II, kombinacije ATC oznaka: C09DA04
Pharmacotherapeutic group: angiotensin-II antagonists, combinations ATC code: C09D A04
Farmakoterapevtska skupina: antagonisti angiotenzina II, kombinacije ATC oznaka: C09DA04.
Pharmacotherapeutic group: angiotensin-II antagonists, combinations ATC code: C09DA04.
Farmakoterapevtska skupina: antagonisti angiotenzina II, kombinacije ATC oznaka: C09DA04.
Pharmacotherapeutic group: Anthelmintics, benzimidazole and related substances – fenbendazole.
Farmakoterapevtska skupina: anthelmintiki, benzimidazol in sorodne učinkovine – fenbendazol.
Pharmacotherapeutic group: Anti-anaemic preparations, other antianemic preparations, ATC Code: B03XA02.
Farmakoterapevtska skupina: Zdravila za zdravljenje slabokrvnosti, druga zdravila za zdravljenje slabokrvnosti, oznaka ATC: B03XA02.
Pharmacotherapeutic group: Anti-hypertensives, other anti-hypertensives, ATC code: C02KX02
Farmakoterapevtska skupina: Antihipertenzivi, drugi antihipertenzivi, oznaka ATC: C02KX02
Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06
Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna (oksikami) Oznaka ATCvet: QM01AC06
Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids (oxicams), ATC vet code: QM01AC06
Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila (oksikami), Oznaka ATC vet: QM01AC06
Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids (oxicams).
Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna zdravila (oksikami).
Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids, ATC vet code: QM01AH90.
Farmakoterapevtska skupina: protivnetna zdravila in zdravila proti revmi, nesteroidna zdravila, Veterinarska koda ATC: QM01AH90.
Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids, coxibs.
Farmakoterapevtska skupina: Protivnetna in antirevmatična zdravila, nesteroidi, koksibi.
Pharmacotherapeutic group: Anti-inflammatory and antirheumatic products, non-steroids (oxicams) ATC vet code: QM01AC06
Farmakoterapevtska skupina: Protivnetna in protirevmatična zdravila, nesteroidna (oksikami) ATC vet: QM01AC06
Pharmacotherapeutic group: Anti-inflammatory and antirheumatic products, non-steroids (oxicams) ATC vet code: QM01AC06
Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna (oksikami) Oznaka ATCvet: QM01AC06
Pharmacotherapeutic group: Anti-inflammatory and antirheumatic products, non-steroids (oxicams), ATCvet code: QM01AC06
Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna zdravila Oznaka ATCvet: QM01AC06
Pharmacotherapeutic group: Anti-inflammatory and antirheumatic products, non-steroids, coxibs.
Farmakoterapevtska skupina: Protivnetna in antirevmatična zdravila, nesteroidi, koksibi.
Pharmacotherapeutic group: Anti-Parkinson drugs, dopaminergic agents, ATC code: N04BA02 Mechanism of action
Farmakoterapevtska skupina: antiparkinsoniki, dopaminergiki, oznaka ATC: N04BA02 Mehanizem delovanja
Pharmacotherapeutic group: Anti-Parkinson-Drugs, Monoamine oxidase -B inhibitors, ATC code: N04BD02
Farmakoterapevtska skupina: antiparkinsoniki, zaviralci monoaminooksidaz tipa B, oznaka ATC: N04BD02
Pharmacotherapeutic group: Antianaemic - ATC code: B03XA.
Farmakoterapevtska skupina: zdravila za zdravljenje slabokrvnosti – oznaka ATC: B03XA.
Pharmacotherapeutic group: Antianaemic - ATC code: B03XA..
Farmakoterapevtska skupina: zdravila za zdravljenje slabokrvnosti – oznaka ATC: B03XA.
Pharmacotherapeutic group: Antibacterials for systemic use, glycopeptide antibacterials, ATC code: J01XA03
Farmakoterapevtska skupina: Druge protimikrobne učinkovine, glikopeptidni antibiotiki, oznaka ATC: J01XA03
Pharmacotherapeutic group: antibacterials for systemic use, macrolides.
Farmakoterapevtska skupina: : zdravila za sistemsko zdravljenje bakterijskih infekcij, makrolidni antiobiotiki
Pharmacotherapeutic group: antibacterials for systemic use, macrolides.
Farmakoterapevtska skupina: antibakterijska sredstva za sistemsko uporabo, makrolid.
Pharmacotherapeutic group: antibacterials for systemic use, macrolides.
Farmakoterapevtska skupina: antibakterijsko sredstvo za sistemsko uporabo, makrolidi.
Pharmacotherapeutic group: Anticholinergics; ATC Code: R03BB05.
Farmakoterapevtska skupina: antiholinergiki; oznaka ATC: R03BB05.
Pharmacotherapeutic group: anticholinesterases, ATC code: N06D A03
Farmakoterapevtska skupina: antiholinesteraze, oznaka ATC: N06DA03.
Pharmacotherapeutic group: Antidotes, ATC code: V03AB33 Mechanism of action
Farmakoterapevtska skupina: Antidoti, oznaka ATC: V03AB33 Mehanizem delovanja
Pharmacotherapeutic group: Antiemetics and antinauseants, serotonin (5HT3) antagonists ATC code: A04AA02
Farmakoterapevtska skupina: Antiemetiki in zdravila proti slabosti, antagonisti serotonina (5HT3), oznaka ATC: A04AA02.
Pharmacotherapeutic group: Antiepileptics Other antiepileptics imepitoin ATCvet code: QN03AX90
Farmakoterapevtska skupina: zdravila proti epilepsiji/druga zdravila proti epilepsiji, imepitoin Oznaka ATC vet: QN03AX90
Pharmacotherapeutic group: antiepileptics, other antiepileptics, ATC code: N03AX14
Farmakoterapevtska skupina: antiepileptiki, drugi antiepileptiki, Oznaka ATC: N03AX14.
Pharmacotherapeutic group: Antiepileptics, other antiepileptics, ATC code: N03AX17 Mechanism of action
Farmakoterapevtska skupina: antiepileptiki, drugi antiepileptiki, oznaka ATC: N03AX17 Mehanizem delovanja
Pharmacotherapeutic group: Antiepileptics, other antiepileptics, ATC code: N03AX17 Mechanism of action
Farmakoterapevtska skupina: antiepileptiki, drugi antiepileptiki, oznaka ATC: N03AX17 Mehanizmi delovanja
Pharmacotherapeutic group: antiepileptics, other antiepileptics, ATC code: N03AX23 Mechanism of action
Farmakoterapevtska skupina: antiepileptiki, drugi antiepileptiki; oznaka ATC: N03AX23 Mehanizem delovanja
Pharmacotherapeutic group: Antihaemorrhagic, blood coagulation factor IX; ATC code: B02BD09 Mechanism of action
Farmakoterapevtska skupina: antihemoragiki, krvni koagulacijski faktor IX; oznaka ATC: B02BD09 Mehanizem delovanja
Pharmacotherapeutic group: Antihaemorrhagics Blood Coagulation factor XIII, ATC code: B02BD11.
Farmakoterapevtska skupina: antihemoragiki, krvni koagulacijski faktor XIII, oznaka ATC: B02BD11.
Pharmacotherapeutic group: antihaemorrhagics, blood coagulation factor IX, ATC code: B02BD04 Mechanism of action
Farmakoterapevtska skupina: antihemoragiki, koagulacijski faktor IX,oznaka ATC: B02BD04 Mehanizem delovanja
Pharmacotherapeutic group: antihaemorrhagics, blood coagulation factor VIII, ATC code: B02BD02 Mechanism of action
Farmakoterapevtska skupina: antihemoragiki, koagulacijski faktor VIII, oznaka ATC: B02BD02 Mehanizem delovanja
Pharmacotherapeutic group: Antihaemorrhagics: Blood coagulation factors, von Willebrand factor and coagulation factor VIII in combination.
Farmakoterapevtska skupina: Antihemoragiki: Krvni koagulacijski faktorji, kombinacija von Willebrandovega faktorja in koagulacijskega faktorja VIII.
Pharmacotherapeutic group: antihemorrhagics: blood coagulation factor VIII, ATC code: B02BD02 Mechanism of action
Farmakoterapevtska skupina: antihemoragiki, koagulacijski faktor VIII, oznaka ATC: B02BD02 Mehanizem delovanja
Pharmacotherapeutic group: antihemorrhagics: blood coagulation factor VIII, ATC code: B02BD02 Mechanism of action
Flokkun eftir verkun: Blæðingalyf: storkuþáttur VIII, ATC-flokkur: B02BD02 Verkunarháttur
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27
Farmakoterapevtska skupina: antihistaminiki za sistemsko zdravljenje – antagonist H1 receptorjev, Oznaka ATC: R06A X27
Pharmacotherapeutic group: Antihypertensives for pulmonary arterial hypertension, ATC code: C02KX05
Farmakoterapevtska skupina: antihipertenzivi za pljučno arterijsko hipertenzijo, oznaka ATC: C02KX05
Pharmacotherapeutic group: Antiinfectives for systemic use, pleuromutilins.
Farmakoterapevtska skupina: Antiinfekcijska sredstva za sistemsko uporabo, pleuromutilini.
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATC vet code: QM01AC06
Farmakoterapevtska skupina protivnetna in protirevmatična zdravila, nesteroidna (oksikami) Oznaka ATCvet: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06
Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna (oksikami) ATC vet: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06
Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna (oksikami) Oznaka ATCvet: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06.
Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna (oksikami) Oznaka ATC vet: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06.
Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna (oksikami) Oznaka ATCvet: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams).
Farmakoterapevtska skupina: Nesteroidna protivnetna in protirevmatična zdravila; oksikami.
Pharmacotherapeutic group: Antimetabolites, pyrimidine analogues, ATC code: L01BC01 Mechanism of action
Farmakoterapevtska skupina: antimetaboliti, analogi pirimidinskih baz, oznaka ATC: L01BC01 Mehanizem delovanja
Pharmacotherapeutic group: Antimycobacterials, antibiotics, ATC code: J04AK06.
Farmakoterapevtska skupina: Učinkovine za zdravljenje infekcij z mikobakterijami, antibiotiki, oznaka ATC: J04AK06.
Pharmacotherapeutic group: antimycotics for systemic use, ATC code: J02AX04 Mechanism of action
Farmakoterapevtska skupina: antimikotiki za sistemsko zdravljenje, oznaka ATC: J02AX04 Mehanizem delovanja
Pharmacotherapeutic group: Antimycotics for systemic use-triazole derivatives, ATC code: J02A C04.
Farmakoterapevtska skupina: Antimikotiki za sistemsko zdravljenje – derivati triazola Oznaka ATC: J02A C04.
Pharmacotherapeutic group: antineoplastic agent, folic acid analogues, ATC code: L01BA04
Farmakoterapevtska skupina: zdravila z delovanjem na novotvorbe (citostatiki), analogi folne kisline, ATC oznaka: L01BA04
Pharmacotherapeutic group: Antineoplastic agent, other antineoplastic agents, monoclonal antibodies, ATC code: L01XC14
Farmakoterapevtska skupina: zdravila z delovanjem na novotvorbe (citostatiki), druga zdravila z delovanjem na novotvorbe (citostatiki), monoklonska protitelesa, oznaka ATC: L01XC14
Pharmacotherapeutic group: Antineoplastic agent, other antineoplastic agents, protein kinase inhibitor, ATC code: L01XE07
Farmakoterapevtska skupina: Zdravila z delovanjem na novotvorbe (citostatiki), druga zdravila z delovanjem na novotvorbe (citostatiki), zaviralci proteinskih kinaz, oznaka ATC: L01XE07
Pharmacotherapeutic group: antineoplastic agent, protein kinase inhibitor, ATC code: L01XE26.
Farmakoterapevtska skupina: zdravila z delovanjem na novotvorbe (citostatiki), zaviralci proteinske kinaze, oznaka ATC: L01XE26.
Pharmacotherapeutic group: Antineoplastic agent, Sensitizers used in photodynamic/radiation therapy, ATC code: L01XD04
Farmakoterapevtska skupina: antineoplastično zdravilo, senzibilizatorji za fotodinamično/obsevalno zdravljenje, oznaka ATC: L01XD04
Pharmacotherapeutic group: Antineoplastic agents - Other alkylating agents, ATC code: L01A X03 Mechanism of action
Farmakoterapevtska skupina: Antineoplastična zdravila - Drugi alkilirajoči citostatiki, oznaka ATC: L01A X03
Pharmacotherapeutic group: Antineoplastic agents, Alkylating Agents, ATC code: L01AC01 Mechanism of action
Farmakoterapevtska skupina: antineoplastiki, alkilacijska sredstva, oznaka ATC: L01AC01
Pharmacotherapeutic group: Antineoplastic agents, Alkylating Agents, ATC code: L01AC01 Mechanism of action
Farmakoterapevtska skupina: antineoplastiki, alkilacijska sredstva, oznaka ATC: L01AC01 Mehanizem delovanja
Pharmacotherapeutic group: antineoplastic agents, antimetabolites, purine analogues, ATC code: L01BB02
Farmakoterapevtska skupina: antineoplastiki, antimetaboliti, analogi purinskih baz, oznaka ATC: L01BB02
Pharmacotherapeutic group: Antineoplastic agents, ATC code: L01XX45
Farmakoterapevtska skupina: Zdravila z delovanjem na novotvorbe (citostatiki), oznaka ATC: L01XX45
Pharmacotherapeutic group: antineoplastic agents, folic acid analogues, ATC code: L01BA04
Farmakoterapevtska skupina: antineoplastične učinkovine, analogi folne kisline, oznaka ATC: L01BA04
Pharmacotherapeutic group: Antineoplastic agents, other alkylating agents, ATC code: L01A X03.
Farmakoterapevtska skupina: Antineoplastična zdravila – drugi alkilirajoči citostatiki, oznaka ATC: L01A X03
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX05.
Farmakoterapevtska skupina: Antineoplastiki, drugi antineoplastiki, oznaka ATC: L01XX05.
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, protein- kinase inhibitors, ATC code: L01XE11
Farmakoterapevtska skupina: Zdravila z delovanjem na novotvorbe, druga zdravila z delovanjem na novotvorbe, zaviralci proteinskih kinaz, oznaka ATC: L01XE11
Pharmacotherapeutic group: antineoplastic agents, plant alkaloids and other natural products,taxanes, ATC Code: L01CD02
Farmakoterapevtska skupina: Zdravila z delovanjem na novotvorbe (citostatiki), Rastlinski alkaloidi in druge naravne učinkovine (zaviralci mitoze), Taksani, oznaka ATC: L01CD02
Pharmacotherapeutic group: antineoplastic agents, plant alkaloids and other natural products,taxanes, ATC Code: L01CD02
Farmakoterapevtska skupina: Zdravila z delovanjem na novotvorbe (citostatiki), Rastlinski alkaloidi in druge naravne učinkovine (zaviralci mitoze),Taksani, oznaka ATC: L01CD02
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors, ATC code: L01XE14.
Farmakoterapevtska skupina: zdravila z delovanjem na novotvorbe, zaviralci proteinske kinaze; oznaka ATC: L01XE14
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors, ATC code: L01XE17
Farmakoterapevtska skupina: zdravila z delovanjem na novotvorbe, zaviralci proteinske kinaze; oznaka ATC: L01XE17
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitors, ATC code: L01XE29
Farmakoterapevtska skupina: Zdravila z delovanjem na novotvorbe (citostatiki), Inhibitorji proteinske kinaze, oznaka ATC: L01XE29.
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors.
Farmakoterapevtska skupina: zdravila proti novotvorbam, zaviralci proteinskih kinaz.
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors; ATC code: L01X E09
Farmakoterapevtska skupina: zdravila z delovanjem na novotvorbe, zaviralci proteinske kinaze; oznaka ATC: L01X E09
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors; ATC code: L01XE04 Mechanism of action
Farmakoterapevtska skupina: antineoplastiki, zaviralci protein-kinaze, oznaka ATC: L01XE04 Mehanizem delovanja
Pharmacotherapeutic group: antineoplastic agents, taxanes, ATC Code: L01CD02 Mechanism of action
Farmakoterapevtska skupina: Zdravila z delovanjem na novotvorbe, taksani, oznaka ATC: L01CD02 Mehanizem delovanja
Pharmacotherapeutic group: Antineoplastic agents; Other antineoplastic agents ATC code: L01XX02
Farmakoterapevtska skupina: Zdravila z delovanjem na novotvorbe (citostatiki); Druga zdravila z delovanjem na novotvorbe (citostatiki) oznaka ATC: L01XX02
Pharmacotherapeutic group: antiobesity preparations, excl. diet products, peripherally acting antiobesity products, ATC code A08AB01.
Farmakoterapevtska skupina: zdravila za zdravljenje debelosti brez proizvodov za dieto, periferno delojoča zdravila za zdravljenje debelosti, oznaka ATC: A08AB01
Pharmacotherapeutic group: antiparasitic product, other anthelmintic agents.
Farmakoterapevtska skupina: antiparazitik, drugi antihelmintiki.